What is the recommended monitoring and management of inter‑ocular pressure differences in a patient with multiple sclerosis?

Interocular Ophthalmology in Multiple Sclerosis

In patients with multiple sclerosis, inter-eye (interocular) differences should be monitored using optical coherence tomography (OCT) to detect optic nerve involvement, not intraocular pressure differences, as MS is actually associated with lower—not higher—IOP and does not require glaucoma-type pressure monitoring.

Understanding the Clinical Context

The question appears to conflate two distinct concepts: inter-eye differences in retinal structure (which are clinically relevant in MS) versus intraocular pressure monitoring (which is not a primary concern in MS management). Let me clarify both:

What Actually Matters in MS: Retinal Structural Differences

The 2024 revised McDonald criteria now recognize optic nerve involvement as a topography for dissemination in space, making inter-eye OCT measurements diagnostically important 1. The optimal approach for detecting unilateral optic nerve involvement uses:

• Combined thresholds provide superior diagnostic accuracy: Concurrent peri-papillary retinal nerve fiber layer (pRNFL) inter-eye difference ≥5 μm AND ganglion cell-inner plexiform layer (GCIPL) inter-eye difference ≥3 μm yields 72.5% sensitivity, 86.6% specificity, and 76.7% positive predictive value 1

• Alternative single-measure thresholds (if combined measurement unavailable):

  • pRNFL inter-eye difference ≥6 μm (80% AUC) 1
  • GCIPL inter-eye difference ≥4 μm (83% AUC) 1
  • GCL alone: ≥2 μm or ≥0.06 mm³ (79% AUC, 58.9% sensitivity, 85.1% specificity) 2

• Temporal-quadrant pRNFL measurements offer no additional benefit and should not be prioritized 1

Monitoring Frequency and Stability

Inter-eye differences remain stable over time (median 5.1 years of follow-up), are unaffected by the number of prior optic neuritis episodes, and do not vary by sex 1. This means:

• Baseline OCT establishes optic nerve involvement for McDonald criteria
• Serial monitoring is not required specifically for inter-eye differences unless new visual symptoms emerge
• Black patients may have slightly higher inter-eye differences than White patients, but optimal diagnostic thresholds remain comparable across races 1

Intraocular Pressure in MS: A Non-Issue

MS patients actually have significantly LOWER intraocular pressure compared to controls (mean 12.3 mm Hg vs 17.0 mm Hg, accounting for 53% of IOP variability) 3. This means:

• Standard glaucoma-type IOP monitoring protocols are not indicated solely based on MS diagnosis
• Inter-eye IOP differences are not a recognized monitoring parameter in MS
• If elevated IOP or glaucoma is suspected, follow standard glaucoma guidelines 4, 5 independent of MS status

Clinical Algorithm for MS Patients

For newly diagnosed or established MS patients:

1. Obtain baseline OCT measuring both pRNFL and GCIPL thickness in both eyes
2. Calculate inter-eye differences to establish optic nerve involvement for McDonald criteria
3. Use combined thresholds (pRNFL ≥5 μm AND GCIPL ≥3 μm) for highest specificity when both measures available
4. Repeat OCT only when:
   • New visual symptoms develop
   • Clinical suspicion of new optic neuritis
   • Standard MS monitoring protocols dictate (not specifically for inter-eye differences)

Do NOT routinely monitor inter-eye IOP differences as this is not evidence-based in MS management.

Common Pitfalls to Avoid

• Confusing structural retinal measurements with pressure measurements: OCT measures tissue thickness; tonometry measures fluid pressure—these are entirely different parameters
• Over-monitoring stable inter-eye differences: Once established, these remain stable and don't require frequent reassessment 1
• Using temporal-quadrant pRNFL alone: This has inferior diagnostic performance 1
• Applying glaucoma monitoring protocols to MS patients: Unless concurrent glaucoma risk factors exist, standard IOP monitoring is not MS-specific